Kosma VM - Search Results

1

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

Kabisch M, Lorenzo Bermejo J, Dünnebier T, Ying S, Michailidou K, Bolla MK, Wang Q, Dennis J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Peeters S, Weltens C, Couch FJ, Olson JE, Wang X, Purrington K, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, dos-Santos-Silva I, Johnson N, Fletcher O, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Schmidt MK, Broeks A, Cornelissen S, Hogervorst FB, Li J, Brand JS, Humphreys K, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marmé F, Yang R, Bugert P, González-Neira A, Benitez J, Pilar Zamora M, Arias Perez JI, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N; kConFab Investigators; Australian Ovarian Cancer Study Group; Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindblom A, Margolin S, Hooning MJ, Hollestelle A, Kriege M, Koppert LB, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slettedahl S, Toland AE, Vachon C, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA, Ruebner M, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Ash… See abstract for full author list ➔ Kabisch M, et al. Among authors: kosma vm. Carcinogenesis. 2015 Feb;36(2):256-71. doi: 10.1093/carcin/bgu326. Epub 2015 Jan 13. Carcinogenesis. 2015. PMID: 25586992 Free PMC article.

2

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.

Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kosma vm. Pharmacogenetics. 2002 Jan;12(1):67-72. doi: 10.1097/00008571-200201000-00009. Pharmacogenetics. 2002. PMID: 11773866

3

Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: kosma vm. Pharmacogenetics. 2004 Apr;14(4):239-45. doi: 10.1097/00008571-200404000-00003. Pharmacogenetics. 2004. PMID: 15083068

4

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Pellikainen JM, et al. Among authors: kosma vm. Clin Cancer Res. 2004 Nov 15;10(22):7621-8. doi: 10.1158/1078-0432.CCR-04-1061. Clin Cancer Res. 2004. PMID: 15569994

5

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: kosma vm. Int J Cancer. 2005 Apr 20;114(4):579-84. doi: 10.1002/ijc.20677. Int J Cancer. 2005. PMID: 15609332

6

An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.

Hartikainen JM, Tuhkanen H, Kataja V, Dunning AM, Antoniou A, Smith P, Arffman A, Pirskanen M, Easton DF, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: kosma vm. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):75-80. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668479

7

Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.

Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. Sillanpää P, et al. Among authors: kosma vm. Pharmacogenet Genomics. 2005 Oct;15(10):749-52. doi: 10.1097/01.fpc.0000172240.34923.46. Pharmacogenet Genomics. 2005. PMID: 16141802

8

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A. Metsola K, et al. Among authors: kosma vm. Breast Cancer Res. 2005;7(6):R987-97. doi: 10.1186/bcr1333. Epub 2005 Oct 11. Breast Cancer Res. 2005. PMID: 16280050 Free PMC article.

9

Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.

Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: kosma vm. Clin Cancer Res. 2006 Mar 1;12(5):1454-62. doi: 10.1158/1078-0432.CCR-05-1417. Clin Cancer Res. 2006. PMID: 16533768

10

Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas.

Tuhkanen H, Anttila M, Kosma VM, Heinonen S, Juhola M, Helisalmi S, Kataja V, Mannermaa A. Tuhkanen H, et al. Among authors: kosma vm. Int J Cancer. 2006 Sep 15;119(6):1345-53. doi: 10.1002/ijc.21785. Int J Cancer. 2006. PMID: 16642473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters